SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-23-057845
Filing Date
2023-07-18
Accepted
2023-07-18 16:05:18
Documents
13
Period of Report
2023-07-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea181967-8k425a1_phoenix.htm   iXBRL 8-K/A 33624
  Complete submission text file 0001213900-23-057845.txt   266074

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pbax-20230707.xsd EX-101.SCH 4139
3 XBRL DEFINITION FILE pbax-20230707_def.xml EX-101.DEF 27294
4 XBRL LABEL FILE pbax-20230707_lab.xml EX-101.LAB 37791
5 XBRL PRESENTATION FILE pbax-20230707_pre.xml EX-101.PRE 25914
7 EXTRACTED XBRL INSTANCE DOCUMENT ea181967-8k425a1_phoenix_htm.xml XML 7738
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40877 | Film No.: 231094292
SIC: 2836 Biological Products, (No Diagnostic Substances)